Leading BioSciences Announces Positive Topline Data from Open-Label Gastrointestinal Surgery Study
January 08, 2021 08:30 ET
|
Leading BioSciences
CARLSBAD, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Leading BioSciences, Inc. (“LBS”), a privately held company that recently entered into a definitive agreement for a reverse merger with Seneca...
Leading BioSciences Receives IND Clearance for Phase 2 COVID-19 Study
May 15, 2020 09:00 ET
|
Leading BioSciences
CARLSBAD, Calif., May 15, 2020 (GLOBE NEWSWIRE) -- Leading BioSciences, Inc. (LBS), a drug development company focused on improving human health through therapeutic protection of the intestinal...
Leading BioSciences Announces Potential for Investigational Drug LB1148 to Treat Multiple Organ Dysfunction Syndrome in COVID-19 Patients
April 07, 2020 09:00 ET
|
Leading BioSciences
CARLSBAD, Calif., April 07, 2020 (GLOBE NEWSWIRE) -- Leading BioSciences, a drug development company focused on improving human health through therapeutic protection of the intestinal mucosal...
Leading BioSciences Announces Top Line Phase 2 Data Demonstrating LB1148 Achieves Primary Endpoint with Statistically Significant Improvement in Bowel Function Following Cardiovascular Surgery
March 24, 2020 09:35 ET
|
Leading BioSciences
CARLSBAD, Calif., March 24, 2020 (GLOBE NEWSWIRE) -- Leading BioSciences, a drug development company focused on improving human health through therapeutic protection of the intestinal mucosal...
Leading BioSciences to Present at Planet MicroCap Showcase 2019
April 25, 2019 08:05 ET
|
Leading BioSciences
CARLSBAD, Calif., April 25, 2019 (GLOBE NEWSWIRE) -- Leading BioSciences, a drug development company focused on improving human health through therapeutic protection of the Gastrobiome™, today...
Leading BioSciences to Present at Biotech Showcase 2019
January 02, 2019 08:05 ET
|
Leading BioSciences
CARLSBAD, Ca., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Leading BioSciences, a drug development company focused on improving human health through therapeutic protection of the Gastrobiome™, today announced...
Leading BioSciences Announces Appointments of James R. Neal and James Sapirstein to Board of Directors
October 30, 2018 08:05 ET
|
Leading BioSciences
Experienced Industry Executives Provide Company with Broad Life Science Industry Expertise Including Drug Development and Commercialization CARLSBAD, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) --...
Leading BioSciences Reports Positive Interim Results from Phase 2 Trial of LB1148 in Patients Undergoing Major Surgery
June 19, 2018 07:05 ET
|
Leading BioSciences
CARLSBAD, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- Leading BioSciences, a drug development company focused on improving human health through therapeutic protection of the Gastrobiome™, today...